Bellevue Life Sciences Acquisition Corp. (BLAC)
NASDAQ: BLAC · Real-Time Price · USD
11.60
-0.06 (-0.51%)
Nov 20, 2024, 4:00 PM EST - Market closed
BLAC Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 2.24 | 1.83 | 0.04 | 0 | 0.03 |
| Operating Expenses | 2.24 | 1.83 | 0.04 | 0 | 0.03 |
| Operating Income | -2.24 | -1.83 | -0.04 | -0 | -0.03 |
| Interest & Investment Income | 2.14 | 2.78 | - | - | - |
| Pretax Income | -0.1 | 0.94 | -0.04 | -0 | -0.03 |
| Income Tax Expense | 0.38 | 0.54 | - | - | - |
| Net Income | -0.47 | 0.4 | -0.04 | -0 | -0.03 |
| Net Income to Common | -0.47 | 0.4 | -0.04 | -0 | -0.03 |
| Shares Outstanding (Basic) | 6 | 8 | 2 | 2 | 2 |
| Shares Outstanding (Diluted) | 6 | 8 | 2 | 2 | 2 |
| Shares Change (YoY) | -11.85% | 414.65% | - | - | - |
| EPS (Basic) | -0.09 | 0.05 | -0.02 | -0.00 | -0.02 |
| EPS (Diluted) | -0.09 | 0.05 | -0.02 | -0.00 | -0.02 |
| Free Cash Flow | -1.96 | -0.82 | -0 | -0 | -0.03 |
| Free Cash Flow Per Share | -0.36 | -0.11 | -0.00 | -0.00 | -0.02 |
| EBIT | -2.24 | -1.83 | -0.04 | -0 | -0.03 |
| Effective Tax Rate | - | 57.25% | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.